Reddy VijayBhaskar Regalla

Title: Reddy VijayBhaskar Regalla: Innovator in Pharmaceutical Chemistry

Introduction

Reddy VijayBhaskar Regalla is a notable inventor based in Krishna District, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of polymorphic forms of Dasatinib. His innovative work has implications for the treatment of various diseases, showcasing the importance of research and development in the pharmaceutical industry.

Latest Patents

Reddy VijayBhaskar Regalla holds a patent for "Polymorphic forms of Dasatinib." This invention provides for the dasatinib-thymine co-crystal and dasatinib-adenine co-crystal. Additionally, it includes dasatinib-butanediol solvate and various crystalline forms of dasatinib, such as crystalline dasatinib-(±)-1, 2-Butanediol, crystalline dasatinib (R)-1, 2-Butanediol, and crystalline dasatinib (S)-1, 2-Butanediol. The patent also outlines processes for the preparation of amorphous dasatinib and anhydrous dasatinib, as well as a method for preparing dasatinib monohydrate from anhydrous dasatinib. This patent highlights his innovative approach to enhancing the efficacy and stability of pharmaceutical compounds.

Career Highlights

Reddy VijayBhaskar Regalla is associated with Biocon Limited, a leading biopharmaceutical company. His work at Biocon has allowed him to contribute to the advancement of drug formulations and delivery systems. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Reddy has collaborated with notable colleagues, including Ramakrishna Parameshwar Bhat and Jithendrababu Raghunadhachetty. These collaborations have fostered a productive environment for innovation and research, leading to significant advancements in their respective fields.

Conclusion

Reddy VijayBhaskar Regalla's contributions to pharmaceutical chemistry, particularly through his patent on Dasatinib, demonstrate his commitment to innovation in the industry. His work not only enhances drug formulations but also paves the way for future research and development in pharmaceuticals.